Labtec GmbH and GlaxoSmithKline Finalize License Agreement

LANGENFELD/RHEINLAND, Germany--(BUSINESS WIRE)--In a recently finalized license agreement, the Consumer Healthcare division of GlaxoSmithKline acquired the exclusive marketing rights for a new topical patch for the treatment of cold sores from Labtec GmbH, the transdermal and topical patch specialist based in Langenfeld, Germany. The agreement designates Labtec as the exclusive manufacturer.

MORE ON THIS TOPIC